Kaz J. Nelson, MD

Kaz J. Nelson, MD, is a Fellow of the American Board of Psychiatry and Neurology and serves as Vice Chair for Education in the UMN Department of Psychiatry & Behavioral Sciences. Dr. Nelson practices at the University of Minnesota Medical Center and her clinical interests lie in the area of best practices in the diagnosis and management of severe personality disorders, suicide, and psychotherapeutic communication with patients in acute settings. Dr. Nelson also serves in the position of Associate Designated Institutional Official with leadership responsibilities across residency and fellowship programs. Dr. Nelson is an Honors graduate of the University of Minnesota-Morris, and received her medical degree and psychiatry residency training from the University of Minnesota Medical School. Dr. Nelson is the 2018 Minnesota Psychiatric Society "Psychiatrist of the Year" and a "2018 Exemplary Psychiatrist" awarded for the state of Minnesota by the National Alliance on Mental Illness. Dr. Nelson developed an openly accessible podcast with her brother, George, called "The Mind Deconstructed" which aims to serve the general community to demystify and increase understanding of common mental health conditions.

American Association of Directors of Psychiatric Residency Training

American Psychiatric Association, Fellow

Minnesota Psychiatric Society

Association for Academic Psychiatry

Peer-Reviewed Publications

1.Schreiner M, Klimes-Dougan B, Mueller B, Nelson KJ, Lim K, Cullen K. (2019) “Neurocircuitry Associated with Symptom Dimensions at Baseline and with Change in Borderline Personality Disorder.”Science Direct.

2.Dirlam C, Vallera V, Nelson KJ & Bass DA. (2018) Psychiatry Resident’s Perspective of the “Virtual Preceptor” as an Electronic Medical Record Clinical Education Support Tool. Acad Psychiatry.https://doi.org/10.1007/s40596-017-0880-4.

3.Cullen KR, Klimes-Dougan B, Westlund Schreiner MK, Carstedt P, Marka N, Nelson KJ, Miller MJ, Reigstad K, Westervelt A, Gunlicks-Stoessel M & Eberly LE. (2018) N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study. Journal of Child and Adolescent Psychopharmacology. 28(2) 136-144.

4.Garber C, Bernadino M, Tomashek J & Nelson KJ. (2017) The Development and Implementation of a Patient Continuity Conference in a Psychiatry Residency Program Acad Psychiatry (2017).https://doi.org/10.1007/s40596-017-0749-6.

5.Bernadino M & Nelson KJ. (2017) FIGHT to remember PTSD. Current Psychiatry. 16(8):17-.

6.Cullen KR, Schreiner MW, Mueller B, Klimes-Dougan B, Eberly LE, Carstedt P, Nelson KJ, Miller M & Lim, KO. (2015) N-Acetylcysteine Restored Impaired Amygdala-Insula Resting State Connectivity in Adolescents with Non-Suicidal Self-Injury. Biological Psychiatry, vol 77(9), pp. 110S-110S.

7.Nelson KJ, Zagoloff A, Quinn S, Swanson HE, Garber C, Schulz SC. (2014) Borderline personality disorder: Treatment approaches and perspectives. Clinical Practice. 2014;11(3):341-9. doi: 10.2217/cpr.14.24.

8.Cullen, KR, Eberly, LE, Klimes-Dougan, B, Mueller, BA, Jappe, L, Westlund, MK, Carstedt, P, Nelson, KJ, Miller, M & Lim, KO. (2014) Behavioral and Brain Changes Associated with the Experimental Use of N-Acetylcysteine for Non-suicidal Self-injurious Behavior in Adolescents. Neuropsychopharmacology. (39)S211-S212.

9.Cullen KR, Klimes-Dougan B, LaRiviere L, Houri A., Westlund MK, Lim B, Bortnova A, Nelson KJ, Miller MJ, Schulz SC, Mueller BA, Eberly LE, & Lim, KO. (2013) N-Acetylcysteine for the Treatment of Non-suicidal Self-injurious Behavior in Adolescents: A Preliminary Study. Neuropsychopharmacology. (38)S385-S386.

10.Ranallo PA, Adam TJ, Nelson KJ, Krueger RF, LaVenture M, Chute CG. (2013) Psychological assessment instruments: a coverage analysis using SNOMED CT, LOINC and QS terminology. AMIA Annual Symposium proceedings / AMIA Symposium. 2013:1333-40.

11.Nelson KJ. (2013) Managing borderline personality disorder on general psychiatric units. Psychodynamic Psychiatry. 41(4):563-74. doi: 10.1521/pdps.2013.41.4.563.

12.Nelson KJ. (2011) How to use patient-centered language in documentation. Current Psychiatry. 10(10):70.

13.Nelson K, Schulz SC. (2011) Pharmacologic treatment of borderline personality disorder. Current Psychiatry. 10(8):30-40.

14.Schulz SC, Moen R, Miller M, Long B, Romine A, Nelson K. (2009) Borderline personality disorder: A review of treatment approaches. Minerva Psichiatrica. 50(4):309-18.

Chapters in Books

1.Loeks Johnson A, Wichser L & Nelson KJ. (2019) Pharmacologic interventions for Antagonism and Related Disorders. In “The Handbook of Antagonism: Conceptualizations, Assessment, Consequences, and Treatment of the Low End of Agreeableness, 1^st edition. Miller JW, Lynam D. Academic Press.

2.Homans J & Nelson KJ. (2016) Psychoticism due to Personality Disorders or Stress-Related Phenomena. In "Primer on Schizophrenia and Related Disorders" (Eds. Schulz, SC, Green M, and Nelson, KJ). April 1, 2016, Oxford University Press: New York.

3.Nelson KJ, Miller MJ, Zagoloff A, Westlund M & Schulz SC. (2014) Personality disorders. In: A Concise Guide to Understanding Suicide: Epidemiology, Pathophysiology and Prevention. Nemeroff C, Ruiz P, Koslow SH (eds). Cambridge University Press: United Kingdom.

4.Schulz SC & Nelson KJ. Somatic treatments. In: Textbook of Personality Disorders, Second Edition. Oldham JM, Skodol AE, Bender DS (eds). American Psychiatric Publishing, 2014, 321-343.

Book

1.Primer on Schizophrenia and Related Disorders. Eds. Schulz SC, Green M, and Nelson KJ. April 1, 2016, Oxford University Press: New York.